NSE shareholding pattern
SUN PHARMA ADVANCED RESEARCH COMPANY LIMITED shareholding pattern
As of the Sep 2026 shareholding pattern (quarter ended 2026-09-30), promoters held 65.67%, FIIs 3.74%, and DIIs 0.11% of SUN PHARMA ADVANCED RESEARCH COMPANY LIMITED (SPARC). Against the Jun 2026 pattern, FII holding is down 0.16 percentage points (3.9% → 3.74%), DII up 0.02 points (0.09% → 0.11%), and promoter holding unchanged at 65.67%. The table below shows how promoter, FII, DII and public holding has moved quarter by quarter, taken from the NSE shareholding pattern.
Smart Money Report, Q2 FY27: shareholding patterns as they are filed, 1 Oct 2026 to 21 Oct 2026
Definition
A shareholding pattern is the quarterly breakdown of who owns a listed company, split across promoters, foreign institutional investors (FII), domestic institutional investors (DII), and the public. Indian companies file it every quarter under SEBI listing rules. Source: NSE shareholding pattern.
SUN PHARMA ADVANCED RESEARCH COMPANY LIMITED shareholding by quarter
| Quarter | Promoter % | FII % | DII % | Public % | Filed |
|---|---|---|---|---|---|
| Sep 2026 | 65.67 | 3.74 | 0.11 | 30.48 | 2026-09-30 |
| Jun 2026 | 65.67 | 3.9 | 0.09 | 30.34 | 2026-06-30 |
| May 2026 | 65.67 | 2.48 | 0.1 | 31.75 | 2026-05-19 |
| Mar 2026 | 65.67 | 2.04 | 0.88 | 31.41 | 2026-03-31 |
| Dec 2025 | 65.67 | 2.04 | 0.79 | 31.5 | 2025-12-31 |
| Sep 2025 | 65.67 | 1.76 | 1.04 | 31.53 | 2025-09-30 |
| Jun 2025 | 65.67 | 1.48 | 0.97 | 31.88 | 2025-06-30 |
Disclosures shown are public regulatory filings. Data may be delayed or incomplete. Smart-money entities may no longer hold positions shown. Not investment advice.
Related on Flock
- Smart money moves this filing week (insider trades, bulk deals and stake disclosures from the last 7 days)
- All NSE shareholding patterns (browse every company by name)
- What is a 13F filing? (how the US equivalent disclosure works)
- FII and DII activity, sourced and dated
- Today's NSE and BSE bulk and block deals
- Shareholding patterns for other companies in the same industry: Supriya Lifescience Ltd*, Torrent Pharmaceuticals Limited, Unichem Laboratories Ltd., Viyash Scientific Limited, Windlas Biotech Ltd., Wockhardt Limited, Zydus Lifesciences Limited, Aarti Drugs Ltd
- When smart money's filings overlap (multi-entity disclosure overlap, explained)
Frequently asked questions
What is the promoter holding in SUN PHARMA ADVANCED RESEARCH COMPANY LIMITED?
As of the Sep 2026 shareholding pattern, promoters held 65.67% of SUN PHARMA ADVANCED RESEARCH COMPANY LIMITED (SPARC). Figures are taken from the NSE shareholding pattern filing dated 2026-09-30 and may change each quarter. Not investment advice.
What is the FII holding in SUN PHARMA ADVANCED RESEARCH COMPANY LIMITED?
Foreign institutional investors held 3.74% of SUN PHARMA ADVANCED RESEARCH COMPANY LIMITED as of the Sep 2026 pattern, versus 3.9% in the Jun 2026 pattern. Source: NSE shareholding pattern, quarter ended 2026-09-30. Not investment advice.
How much did FII holding in SUN PHARMA ADVANCED RESEARCH COMPANY LIMITED change in the Sep 2026 quarter?
FII holding in SUN PHARMA ADVANCED RESEARCH COMPANY LIMITED was 3.9% in the Jun 2026 pattern and 3.74% in Sep 2026, a difference of 0.16 percentage points down. Promoter holding was unchanged at 65.67% across the two filings, and both figures are percentages as filed. Source: NSE shareholding pattern, quarter ended 2026-09-30. Not investment advice.
How often is the shareholding pattern updated?
Listed Indian companies disclose their shareholding pattern every quarter under SEBI's listing rules. Flock re-stamps each page when a new quarterly pattern is filed, so the freshness chip reflects the true age of the latest data.
The Smart Money Digest
A free weekly email of notable disclosure activity — every line with its filing date and source link. No advice, just filings. Unsubscribe anytime.